If you are a student, recent graduate or alumni interested in exploring a career in the biotechnology, pharmaceutical and life sciences industries, you are in the right place! Register today to start your job search and be contacted by employers nationwide looking for you! It only takes a few minutes and you will be on your way to the perfect job!
Thursday, December 17, 2009
Arbovax, Inc. has been awarded a $250,000 Strategic Growth Loan (SGL) by the North Carolina Biotechnology Center to help Arbovax develop its proprietary Dengue Fever vaccine platform. “This loan will greatly assist in our product development efforts”, said Arbovax CEO Malcolm Thomas.
“We are working toward testing our technology for a Dengue Fever vaccine in non-human primates in early 2010 and this loan will go a long way to providing the necessary funds to complete these pivotal trials. We are indebted to the Biotechnology Center staff for their support, both financial and technical, and for the confidence they have shown in us during the past two-and-a-half years.” Arbovax is a privately held early-stage biotechnology company developing a novel and innovative technology for creating vaccines against insect-borne viruses.Read Full Article
posted in: News, North Carolina
Phoenix • Tucson • Palm Springs • Sacramento • San Diego • San Francisco • San Jose • Denver • Jacksonville • Miami • Orlando • Tampa • Atlanta • Chicago • Indianapolis • Kansas City • Louisville • New Orleans • Boston • Baltimore • Detroit • Grand Rapids • Minneapolis • Charlotte • Raleigh • Omaha • Atlantic City • Las Vegas • Reno • Buffalo • New York City • Cincinnati • Cleveland • Toledo • Tulsa • Portland • Philadelphia • Pittsburgh • Myrtle Beach • Memphis • Nashville • Austin • Dallas • Houston • San Antonio • Salt Lake City • Richmond • Seattle • Spokane
